Product Images Spironolactone

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Spironolactone NDC 59746-217 by Jubilant Cadista Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

100mglabel

100mglabel

This is a medication information for Spironolactone tablets, USP with 100 mg strength. The dosage information is not available in this text. The medication should be kept out of reach of children and should be dispensed in a tight, light-resistant, and child-resistant container as defined in the USP. It should be stored at a temperature between 20°C to 25°C but can be stored at 15°C to 30°C keeping USP Controlled Room Temperature in mind. This medication is manufactured in India by Jubllant Generics Ltd and marketed in the USA by Jubiant Cadista Pharmaceuticals Inc. The NDC number for this medication is 59746-218-01.*

25mglabel

25mglabel

This text describes the medication Spironolactone, which is available as 25mg tablets. It gives instructions for use, warnings about keeping the medication out of reach of children and protected from light, and information about storage conditions. The medication is manufactured by Jubilant Generics Ltd. in India and marketed by Jubilant Cadista Pharmaceuticals Inc. in the USA. The NDC code for this medication is 59746-216-01.*

50mglabel

50mglabel

Spironolactone is a tablet medication manufactured by Jublant Generics Ltd in India and marketed by Jubiant Cadista Phamaceutcals in the USA. Each tablet contains 50mg of Spironolactone USP. It is advised to read the prescribing information before taking Spironolactone and keep it out of reach of children while protected from light, in a tight and child-resistant container. It should be stored between 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The NDC code for this medication is 59746-217-01.*

Structure

Structure

fig01

fig01

This appears to be a section of a research paper or clinical trial report. The Logerankp value indicates a statistically significant difference between two groups, but the specific comparison is not clear without additional context. The drug "Spironalactone" and a group of 82 individuals are mentioned, as well as a control group of 841 individuals who received a placebo. The timeline of the study is given as "Months: 2". Without further context or information, it is difficult to provide a more specific description or interpretation of this text.*

fig02

fig02

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.